Correlation Between Railway Signal and Ningbo MedicalSystem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Railway Signal and Ningbo MedicalSystem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Railway Signal and Ningbo MedicalSystem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Railway Signal Communication and Ningbo MedicalSystem Biotechnology, you can compare the effects of market volatilities on Railway Signal and Ningbo MedicalSystem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Railway Signal with a short position of Ningbo MedicalSystem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Railway Signal and Ningbo MedicalSystem.

Diversification Opportunities for Railway Signal and Ningbo MedicalSystem

0.94
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Railway and Ningbo is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding Railway Signal Communication and Ningbo MedicalSystem Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ningbo MedicalSystem and Railway Signal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Railway Signal Communication are associated (or correlated) with Ningbo MedicalSystem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ningbo MedicalSystem has no effect on the direction of Railway Signal i.e., Railway Signal and Ningbo MedicalSystem go up and down completely randomly.

Pair Corralation between Railway Signal and Ningbo MedicalSystem

Assuming the 90 days trading horizon Railway Signal Communication is expected to under-perform the Ningbo MedicalSystem. But the stock apears to be less risky and, when comparing its historical volatility, Railway Signal Communication is 2.15 times less risky than Ningbo MedicalSystem. The stock trades about -0.18 of its potential returns per unit of risk. The Ningbo MedicalSystem Biotechnology is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  1,143  in Ningbo MedicalSystem Biotechnology on September 21, 2024 and sell it today you would lose (26.00) from holding Ningbo MedicalSystem Biotechnology or give up 2.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Railway Signal Communication  vs.  Ningbo MedicalSystem Biotechno

 Performance 
       Timeline  
Railway Signal Commu 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Railway Signal Communication are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Railway Signal sustained solid returns over the last few months and may actually be approaching a breakup point.
Ningbo MedicalSystem 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.

Railway Signal and Ningbo MedicalSystem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Railway Signal and Ningbo MedicalSystem

The main advantage of trading using opposite Railway Signal and Ningbo MedicalSystem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Railway Signal position performs unexpectedly, Ningbo MedicalSystem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will offset losses from the drop in Ningbo MedicalSystem's long position.
The idea behind Railway Signal Communication and Ningbo MedicalSystem Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance